Authors: Schiffmann, R Kopp, JB Austin, HA Sabnis, S Moore, DF Weibel, T Balow, JE Brady, RO

Citation: R. Schiffmann et al., Enzyme replacement therapy in Fabry disease - A randomized controlled trial, J AM MED A, 285(21), 2001, pp. 2743-2749

Authors: Gropman, A Levin, S Yao, L Lin, T Suchy, S Sabnis, S Hadley, D Nussbaum, R

Citation: A. Gropman et al., Unusual renal features of Lowe syndrome in a mildly affected boy, AM J MED G, 95(5), 2000, pp. 461-466

Authors: Sabnis, S Block, LH

Citation: S. Sabnis et Lh. Block, Chitosan as an enabling excipient for drug delivery systems - I. Molecularmodifications, INT J BIO M, 27(3), 2000, pp. 181-186

Authors: Sabnis, S Adeyeye, CM

Citation: S. Sabnis et Cm. Adeyeye, Controlled-release hydrophilic tablets for individualized theophylline therapy, DRUG DEV IN, 25(2), 1999, pp. 187-196

Authors: Sabnis, S

Citation: S. Sabnis, Factors influencing the bioavailability of peroral formulations of drugs for dogs, VET RES COM, 23(7), 1999, pp. 425-447